Davis George Eric

Average Profitability
5.04%
Insider Buys Quantity
4
Insider Buys Sum
$44,388.25
Insider Sells Quantity
73
Insider Sells Sum
$61.43M

Insider Activity of Davis George Eric

According to the SEC Form 4 filings, Davis George Eric, being in a position of

  1. EVP, Chief Legal Officer at BioMarin Pharmaceutical Inc.,
    оver the last 12 months, has bought 0 shares, and sold 81066 shares for $6.69M,
    over all time since 2007-02-22, has bought 5993 shares for $44,388, and sold 939831 share for $61.43M.

The largest purchase of all time was on 2008-04-30 and amounted to 1810 shares of BioMarin Pharmaceutical Inc. for $18,770.

The largest sale of all time was on 2015-03-02 and amounted to 46000 shares of BioMarin Pharmaceutical Inc. for $4.98M.

Biography of Davis George Eric

No biography is available at this moment.

2024-05-28SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Legal Officer
40,850
0.0215%
$74.51$3.04M+10.03%
2024-05-02SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Legal Officer
1,850
0.001%
$85.01$157,269-3.9%
2024-03-28SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Legal Officer
24,602
0.0132%
$88.34$2.17M-5.45%
2023-12-13SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Legal Officer
13,764
0.0071%
$95.30$1.31M-13.27%
2023-08-08SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Legal Officer
11,000
0.0058%
$89.42$983,662-3.37%
2022-08-09SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Legal Officer
3,690
0.002%
$96.34$355,495-2.88%
2022-07-08SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Legal Officer
7,398
0.004%
$90.00$665,820+4.47%
2022-04-29SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Legal Officer
15,347
0.0082%
$80.38$1.23M+11.62%
2022-03-21SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
6,129
0.0033%
$81.29$498,226+8.61%
2021-08-02SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
5,518
0.003%
$76.69$423,175+5.07%
2021-05-03SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
4,673
0.0025%
$78.30$365,896+2.59%
2021-04-19SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
2,709
0.0015%
$79.58$215,582+0.87%
2020-05-01SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
12,504
0.007%
$89.38$1.12M-8.01%
2019-11-26SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
6,380
0.0036%
$79.66$508,231+9.47%
2019-03-25SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
6,726
0.0037%
$87.86$590,946-7%
2019-03-19SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
15,814
0.0091%
$93.92$1.49M-9.81%
2018-09-14SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
4,432
0.0025%
$99.45$440,772-9.85%
2018-09-13SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
24,000
0.0135%
$99.57$2.39M-9.95%
2018-03-23SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
6,700
0.0039%
$81.35$545,045+19.53%
2018-03-16SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, General Counsel
7,636
0.0043%
$83.88$640,508+12.06%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.